Theme · live manifest · live theme JSON

Genomics '25: Gene Editing

8 tickers · $10.62B total market cap

Group: Genomics

Genomics '25: Gene Editing tracks 8 publicly listed stocks in this theme: BEAM, CRBU, CRSP, EDIT, NTLA, PRME, SGMO, VERV. See the constituent table for details.

Constituents

Build 20260520T081747

CompanyPrevious Quarter Report DateNext Expected Report DateLast Quarter Earnings Move %Earnings Move %Intra-Quarter Move %Since Last Report %Market capWeight
CRISPR Therapeutics AGCRSP
05/04/2026 (AMC)05/04/2026 (AMC)8.46%1.45%0.96%-9.14%$4.59B12.5000
Beam Therapeutics Inc.BEAM
05/07/2026 (BMO)05/07/2026 (BMO)4.52%-0.06%9.22%-18.53%$2.71B12.5000
Intellia Therapeutics, Inc.NTLA
05/11/2026 (BMO)05/11/2026 (BMO)2.68%-0.71%2.25%-14.65%$1.34B12.5000
Verve Therapeutics, Inc.VERV
08/14/2025 (BMO)0.00%0.00%$994.0M12.5000
Prime Medicine, Inc.PRME
05/07/2026 (BMO)05/07/2026 (BMO)-11.59%-5.87%-17.23%-15.89%$487.7M12.5000
Editas Medicine, Inc.EDIT
05/05/2026 (BMO)05/05/2026 (BMO)32.00%5.83%13.64%-22.52%$240.8M12.5000
Caribou Biosciences, Inc.CRBU
05/07/2026 (AMC)05/07/2026 (AMC)6.43%-0.51%3.30%1.55%$195.4M12.5000
Sangamo Therapeutics, Inc.SGMO
05/14/2026 (AMC)05/14/2026 (AMC)-15.36%0.00%-46.17%6.43%$61.7M12.5000
Average3.39%0.02%-4.26%-10.39%$1.33B12.5000
Median3.60%-0.06%1.61%-14.65%$740.9M12.5000
Std Dev13.43%3.19%17.93%9.92%$1.48B0.0%
Min-15.36%-5.87%-46.17%-22.52%$61.7M12.5000
Max32.00%5.83%13.64%6.43%$4.59B12.5000
% Positive Tickers62.50%28.57%62.50%28.57%

* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.

← All themes